Volume 61, Issue 6 , Pages 945-958, December 2009
Angiogenesis in cutaneous disease: Part II
This review will discuss the role of angiogenesis in specific cutaneous diseases. Scientific evidence now points to the role of angiogenesis in tumor development and many other cutaneous disorders. Angiogenesis is a complex process that involves angiogenic growth factors and inhibitors, many of which could be a potential target for pharmacologic intervention. Antiangiogenic agents have recently been applied to dermatologic diseases with promising efficacy.
Learning objectives
After completing this learning activity, participants should be able to recognize cutaneous diseases where angiogenesis is likely to be an important factor, recognize scenarios where angiogenic therapy may be useful in conjunction with traditional therapies, and be able to use angiogenic-mediating agents in the treatment of dermatologic disease.
Key words: angiogenesis, antiangiogenic agents, dermatology
Funding sources: None.
Conflicts of interest: The authors, editors, and peer reviewers have no relevant financial relationships.
Reprints not available from the authors.
PII: S0190-9622(09)00943-8
doi:10.1016/j.jaad.2009.05.053
© 2009 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
Volume 61, Issue 6 , Pages 945-958, December 2009

